UHS.NYSEUniversal Health Services INC

DEF: Universal Health Services Sets Date for 2025 Annual Stockholder Meeting, Outlines Key Proposals

Sentiment:

Proxy Statement

📋All filings for Universal Health Services INC
🔒Login to Follow

Universal Health Services will hold its annual stockholder meeting virtually on May 14, 2025, to vote on director elections, auditor ratification, and a stockholder proposal regarding annual director elections.

Summary

  • Universal Health Services (UHS) will hold its 2025 Annual Meeting of Stockholders on May 14, 2025, at 10:00 a.m. EDT, in a virtual-only format.
  • Stockholders of record as of March 17, 2025, are entitled to vote.
  • The meeting will address the election of directors, ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and a stockholder proposal to elect each director annually.
  • The Board of Directors recommends voting FOR the election of director nominees, FOR the ratification of PricewaterhouseCoopers LLP, and AGAINST the stockholder proposal to elect each director annually.
  • The proxy statement and annual report are available online.

Sentiment

Score: 7

Explanation: The document is primarily factual and procedural, outlining the agenda and proposals for the annual meeting. The tone is professional and informative, with a slight positive leaning due to the company's emphasis on maximizing shareholder value.

Positives

  • The company is providing equal opportunity for all stockholders to participate in the Annual Meeting online regardless of their geographic location.
  • The Board of Directors is recommending voting FOR the election of director nominees and FOR the ratification of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm.

Negatives

  • The Board of Directors is recommending voting AGAINST the stockholder proposal to elect each director annually.
  • The company is a controlled company, which may limit the influence of some shareholders.

Risks

  • The company's performance could be negatively impacted by the rapidly changing landscape and changes in technology, market structure and regulatory regimes.
  • The company's vulnerability to hostile and potentially abusive takeover tactics could negatively impact shareholder value.
  • The company's officers and directors own 16% of UHS common stock yet have 90% of the voting power, which negatively impacts the long-term performance that shareholders can expect from UHS stock.

Future Outlook

The company will continue to focus on maximizing long-term stockholder value creation and maintaining sound corporate governance principles.

Management Comments

  • Alan B. Miller, Executive Chairman of the Board of Directors: 'Sincerely'
  • Marc D. Miller, Chief Executive Officer and President: 'Sincerely'

Industry Context

The document provides insight into the corporate governance and executive compensation practices within the hospital management industry, offering a glimpse into how UHS aligns executive incentives with company performance and shareholder value.

Comparison to Industry Standards

  • The compensation peer group includes Acadia Healthcare Company, Inc., HCA Healthcare, Inc., and Tenet Healthcare Corporation, among others, indicating a focus on companies of similar size and scope within the healthcare sector.
  • The document mentions that the company's behavioral health results exceed the national average in 8 out of 11 indicators, as measured by The Centers for Medicare and Medicaid Services Inpatient Psychiatric Facility Quality Reporting measures.
  • The document mentions that the average aggregate score for our behavioral health care facilities was 41.4 which is considered a high score by industry standards.

Stakeholder Impact

  • Shareholders are directly impacted through their voting rights and the potential influence on company direction.
  • Employees are indirectly impacted through the company's overall performance and strategic direction.
  • Customers (patients) are indirectly impacted through the company's focus on quality of care and compliance.

Next Steps

  • Stockholders are encouraged to vote by telephone, internet, or mail.
  • Stockholders can attend the Annual Meeting online to listen to the meeting live, submit questions, and vote.
  • The Board of Directors will implement the outcomes of the votes on the proposals.

Key Dates

DateDescription
1978Alan B. Miller founded Universal Health Services.
1986Universal Health Realty Income Trust (UHT) commenced operations.
October 1993The Board of Directors adopted the Executive Retirement Income Plan (ERIP).
December 2010The Board of Directors approved the Company's entering into supplemental life insurance plans and agreements on the lives of our Executive Chairman and his wife.
January 1, 2015The Executive Retirement Income Plan (ERIP) was closed to new participants.
October 2016Amendment to the supplemental life insurance plans and agreements on the lives of our Executive Chairman and his wife.
July 2018The Board of Directors adopted the Supplemental Executive Retirement Income Plan (SERIP).
September 2019Matthew J. Peterson's employment with us commenced as Executive Vice President and President of our Behavioral Health Division.
December 23, 2020Employment agreement with Marc D. Miller was entered into, with an effective date of January 1, 2021.
December 23, 2020Employment agreement with Alan B. Miller was entered into, with an effective date of January 1, 2021.
January 1, 2021Marc D. Miller was appointed Chief Executive Officer and President.
January 1, 2021Alan B. Miller was appointed Executive Chairman of the Board.
March 23, 2022Amendment to the employment agreement with Mr. Marc D. Miller which increased his annual bonus opportunity and annual base salary.
December 2022Edward H. Sim was hired as Executive Vice President, President of our Acute Care Division.
March 2022The contribution, in honor of Alan B. Miller, will be made in four annual installments of $250,000 each, the third of which was made in December of 2024.
October 2023The Company adopted a clawback policy to align with listing rules adopted by NYSE as required by the SEC.
January 17, 2024The Board of Directors adopted an amendment of the amended and restated 2020 Omnibus Stock and Incentive Plan, which was approved by our stockholders at our 2024 Annual Meeting.
February 27, 2024We publicly announced that our initial estimated range of adjusted net income per diluted share attributable to UHS for 2024 was $13.00 to $14.00.
March 21, 2024The Compensation Committee approved specific bonus formulae for the determination of the target annual incentive compensation for the Company's NEOs pursuant to the Plan for the year ending December 31, 2024.
May 15, 20241,097 restricted stock units were issued to each of Nina Chen-Langenmayr, Eileen C. McDonnell, Warren J. Nimetz, Maria R. Singer and Elliot J. Sussman, M.D., with a grant date fair value of $199,917, or $182.24 per share.
August 2024Mr. Peterson served in the Air National Guard (ANG), U.S. Airforce, and was promoted to Brigadier General prior to his retirement from the ANG.
December 2024The third of four annual installments of $250,000 each was made to the Miller Theater.
December 31, 2024The employee population consisted of our full-time, part-time and temporary employees.
February 5, 2025Information is based on Amendment No. 16 to Schedule 13G.
February 8, 2024Information is based on Amendment No. 2 to Schedule 13G.
February 13, 2024Information is based on Amendment No. 11 to Schedule 13G.
February 26, 2025UHS subsidiaries owned and operated more than 350 inpatient facilities and more than 50 outpatient and other facilities in 39 states, Washington, D.C., the United Kingdom and Puerto Rico.
February 27, 2025We publicly announced that our initial estimated range of adjusted net income per diluted share attributable to UHS for 2024 was $13.00 to $14.00.
February 27, 2025Adjusted net income and adjusted net income per diluted share for 2024 and 2023 were publicly disclosed and reconciled to our reported results for each year on the Schedule of Non-GAAP Supplemental Consolidated Statements of Income Information, included with our earnings for the years ended December 31, 2024 and 2023, as filed on Form 8-K.
March 12, 2025Our Compensation Committee determined that, based upon our 2024 actual operating results, 112% of the target Adjusted EBITDA applicable to the 2022 PBRSUs had been achieved and therefore 150% of the target 2022 PBRSUs were earned and vested.
March 17, 2025Record date for voting at the Annual Meeting.
March 19, 2025The Compensation Committee determined that, based upon our actual corporate and divisional operating results during the year ended December 31, 2024, the corporate and divisional financial results were achieved as follows.
March 19, 2025The employment agreement was terminated and replaced with an Agreement with UHS of Delaware, a wholly owned subsidiary of the Company and, the employer of record for the Company's management employees.
April 3, 2025Date of proxy statement.
May 9, 2025Requests for registration must be received no later than 5:00 p.m., Eastern Time, on May 9, 2025.
May 14, 2025Annual Meeting of Stockholders at 10:00 a.m. EDT.
December 4, 2025Deadline for stockholder proposals to be included in the proxy materials for the 2026 Annual Meeting.
January 14, 2026Deadline for stockholder proposals intended to be brought before the annual meeting of stockholders, including a proposal nominating one or more persons for election as directors, be received in writing by our Secretary at the address listed above not later than the close of business on the 90 th day nor earlier than the close of business on the 120 th day prior to the first anniversary of the preceding years annual meeting, for the 2026 Annual Meeting being between January 14, 2026 and February 13, 2026.
February 13, 2026Deadline for stockholder proposals intended to be brought before the annual meeting of stockholders, including a proposal nominating one or more persons for election as directors, be received in writing by our Secretary at the address listed above not later than the close of business on the 90 th day nor earlier than the close of business on the 120 th day prior to the first anniversary of the preceding years annual meeting, for the 2026 Annual Meeting being between January 14, 2026 and February 13, 2026.
January 1, 2027Alan B. Miller will serve as Executive Chairman with a term scheduled to end on January 1, 2027, subject, however, to earlier termination, and subject further to automatic renewal for additional one year periods unless either party elects otherwise.
January 1, 2028Mr. Marc D. Miller will serve as CEO of the Company with a term scheduled to end on January 1, 2028, subject, however, to earlier termination, and subject further to automatic renewal for additional one-year periods unless either party elects otherwise.

Keywords

Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Director Election, Auditor Ratification, Corporate Governance, Virtual Meeting, UHS, Universal Health Services

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.